OrbusNeich Medical's Attributable Profit Jumps 5% in H1

MT Newswires Live

Aug 15

OrbusNeich Medical's (HKG:6929) attributable profit rose 5.1% to $19.8 million in the first half from $18.8 million in the year-ago period, according to a Friday filing with the Hong Kong bourse.

Earnings per share at the medical equipment producer grew 5.3% to $0.0240 from $0.0228 in the prior-year period.

Revenue increased 5.9% to $83.6 million from $78.9 million in the year-ago period.

The company declared an interim dividend of HK$0.15 per share, payable Oct. 6 to shareholders on record as of Sept. 24.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2559391617"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2559391617\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2559391617?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-15 18:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559391617","market":"sh","top_or_hot":-1,"title":"OrbusNeich Medical's Attributable Profit Jumps 5% in H1","media":"MT Newswires Live","content":"<html><body><p> OrbusNeich Medical's (HKG:6929) attributable profit rose 5.1% to $19.8 million in the first half from $18.8 million in the year-ago period, according to a Friday filing with the Hong Kong bourse.</p><p>Earnings per share at the medical equipment producer grew 5.3% to $0.0240 from $0.0228 in the prior-year period.</p><p>Revenue increased 5.9% to $83.6 million from $78.9 million in the year-ago period.</p><p>The company declared an interim dividend of HK$0.15 per share, payable Oct. 6 to shareholders on record as of Sept. 24.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OrbusNeich Medical's Attributable Profit Jumps 5% in H1</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrbusNeich Medical's Attributable Profit Jumps 5% in H1\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-15 18:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> OrbusNeich Medical's (HKG:6929) attributable profit rose 5.1% to $19.8 million in the first half from $18.8 million in the year-ago period, according to a Friday filing with the Hong Kong bourse.</p><p>Earnings per share at the medical equipment producer grew 5.3% to $0.0240 from $0.0228 in the prior-year period.</p><p>Revenue increased 5.9% to $83.6 million from $78.9 million in the year-ago period.</p><p>The company declared an interim dividend of HK$0.15 per share, payable Oct. 6 to shareholders on record as of Sept. 24.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1222","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2559391617","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559391617","pubTimestamp":1755255283,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"OrbusNeich Medical's  attributable profit rose 5.1% to $19.8 million in the first half from $18.8 million in the year-ago period, according to a Friday filing with the Hong Kong bourse.Earnings per share at the medical equipment producer grew 5.3% to $0.0240 from $0.0228 in the prior-year period.Revenue increased 5.9% to $83.6 million from $78.9 million in the year-ago period.The company declared an interim dividend of HK$0.15 per share, payable Oct. 6 to shareholders on record as of Sept. 24.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1222":"医疗保健用品","06929":"业聚医疗"},"translate_title":"OrbusNeich Medical上半年归属利润增长5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06929":0.9},"content_text":"OrbusNeich Medical's (HKG:6929) attributable profit rose 5.1% to $19.8 million in the first half from $18.8 million in the year-ago period, according to a Friday filing with the Hong Kong bourse.Earnings per share at the medical equipment producer grew 5.3% to $0.0240 from $0.0228 in the prior-year period.Revenue increased 5.9% to $83.6 million from $78.9 million in the year-ago period.The company declared an interim dividend of HK$0.15 per share, payable Oct. 6 to shareholders on record as of Sept. 24.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}